AMBS' C4CT Co-Hosting Duties...Ugh! At the last Concussion Summit in January I kept waiting for the focus of the Summit to be on AMBS but it never was. Gerald was co-hosting it, which was nice, but the subject matter discussed involved industry wide issues, and it might have been inappropriate for the "Co Host" to then high-jack the Conference and turn everyone's attention on AMBS' specific products....I guess it would have seemed self-serving for a Co-Host to do that. So I eventually stopped listening to the Conference because frankly, most of what was being discussed did not directly interest me. But that is what a Summit is for, to bring together experts and discuss big general issues that effect the entire industry. That is why I have had a hard time wondering how the actual #C4CT Conference proceedings could possibly be an appropriate forum for AMBS to trumpet LymPro data? I can't imagine very much of the Conference will focus on LymPro? What will probably happen is that AMBS will release the LymPro data in a PR around the time of the Conference so that Gerald can have something fun to speak about with important people in the hallways during Conference breaks.(Insert laughter here) But unless Gerald gets a prominent segment during the Conference for him to turn the entire Conference spotlight on LymPro's break through data, then waiting for #C4CT is not going to help us much. If LymPro does get that spot light during the Conference...then Gerald could smack the ball out of the United Nations Building!!! I hope our "Co-Hosting" duties don't get in the way of allowing that to happen. I've seen the Conference Agenda and there is an hour in the afternoon for Break Through issues. I've got my fingers crossed LymPro will be prominently featured during that hour.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links